Ann-Sofie Sternås

TRUPOINT Partners, Inc. operates as regulatory compliance software and data analytics firm. Its solutions include compliance analytics software and consulting, regression analysis, branch Strategy and HMDA submission software. The company was founded in 2009 and is headquartered in Charlotte, NC.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden.

Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.

Part of GSK Plc, GlaxoSmithKline AB is a company that manufactures pharmaceutical products. GlaxoSmithKline AB is based in Solna, Sweden. Founded in 1983.

IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden.

Part of Thermo Fisher Scientific, Inc., PPD Scandinavia AB is a company that provides research and development in the field of medical science. The company is based in Sundbyberg, Sweden.

Part of Roche Holding AG, Roche AB is a biotechnology company founded in 1896. The company is based in Solna, Sweden and creates innovative treatments to help millions of patients worldwide. Roche actively seeks partnerships with healthcare providers, academia, patient associations, organizations, external companies, and startups to identify needs that form the basis for collaborations. Roche is one of the world's largest research-based biotechnology companies, focusing on advancing science to improve people's lives. The Swedish company develops both drugs and diagnostics and has great respect for the multiple perspectives required to create tomorrow's healthcare.

Sanofi Aventis AB engages in the pharmaceutical industsry. The company is headquartered in Stockholm, Sweden.

CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden.

Almi Stockholm Investeringsfond AB provides financing to small businesses in the early stages. It also offers financial advice to businesses. The company was founded on January 23, 1980 and is headquartered in Stockholm, Sweden.

Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland.

ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden.

NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden.

KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden.

Part of P.B.K. NV, BMS Uthyrning I Kalmar AB is a company that provides heavy equipment rental. The company is based in Kalmar, Sweden. BMS Uthyrning I Kalmar was acquired by Cramo AB from Pellann I Kalmar AB on September 09, 2014.

Almi Invest Stockholm AB operates as a venture capital firms. It provides risk capital. The firm specializes in venture capital investments. The company was founded on September 3, 2008 and is headquartered in Stockholm, Sweden.

Vectura Fastigheter AB owns and manages real estate. Its properties consist of community services, hotels, and offices. The company was founded in 2012 and is headquartered in Stockholm, Sweden.

Indonesia International Institute for Life Sciences (i3l) is a premium life sciences higher education and research institute located in Jakarta, Indonesia. The institute offers ten undergraduate programs, including biomedicine, biotechnology, food science and nutrition, food technology, and pharmacy. The School of Life Sciences at i3l offers undergraduate programs in these fields. The Food Technology program aims to ensure safe manufacture, packaging, and distribution of food, while the Food Science and Nutrition program focuses on the role of food in maintaining future health. The Pharmacy program covers drug discovery, development, clinical trials, drug delivery, drug management, and patient counseling. The institute collaborates with other institutions, including the Business & Hotel Management School in Switzerland, to offer pathway programs.

TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden.

M Von Euler Consulting AB operates as a scientific and technical research & development organization. M Von Euler Consulting AB is based in Stockholm, Sweden. Curt Mikael von Euler-Chelpin has been the CEO of the Swedish company since 2014.

Bostadsrättsföreningen Mälarvik operates as a housing association.